Intraperitoneal Carboplatin for Ovarian Cancer — A Phase 2/3 TrialShoji Nagao, Takayuki Enomoto, Kouji Yamamoto et al.|NEJM Evidence|2023Cited by 31
Overexpression of carbonyl reductase 1 in ovarian cancer cells suppresses proliferation and activates the eIF2 signaling pathwayYuka Kadonosawa, Yoshihito Yokoyama|Oncology Letters|2024Cited by 0
Carbonyl reductase 1-overexpressing exosomes inhibit proliferation of ovarian cancer cellsAnna Takahashi-Ebina, Yoshihito Yokoyama|Institutional Repositories DataBase (IRDB)|2021Cited by 0